|
Robert W. Karr M.D. age 58 has served as a director since June 2005 and currently serves on the Nominating and Corporate Governance Committee. Dr. Karr has served as President of Idera Pharmaceuticals Inc. since December 2005 and he currently serves on its Board of Directors (AMEX: IDP). From 2000-2004 Dr. Karr was a senior executive for Global Research & Development for Pfizer Inc. where he served as Senior Vice President Strategic Management from 2003-2004. Prior to its merger with Pfizer (NYSE: PFE) Dr. Karr served as Vice President Research & Development Strategy for Warner-Lambert Company. Dr. Karr received his B.S. (with honors) from Southwestern University in 1971 and his M.D. from the University of Texas Medical Branch in 1975. Dr. Karr completed his internship and residency in internal medicine at Washington University School of Medicine and served as a faculty member at both the University of Iowa College of Medicine and Washington University School of Medicine. | 